Evidence map›Paper›PMID 34031513›Full record

ArticleJournal of human genetics2021

A patient with Silver-Russell syndrome with multilocus imprinting disturbance, and Schimke immuno-osseous dysplasia unmasked by uniparental isodisomy of chromosome 2.

Kaori Hara-Isono, Keiko Matsubara, Riku Hamada, Shun Shimada, Tomomi Yamaguchi, Keiko Wakui, Osamu Miyazaki, Koji Muroya, Kenji Kurosawa, Maki Fukami and 3 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Case Report: A Novel Homozygous Mutation inFrontiers in genetics · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Kaori Hara-IsonoDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
Keiko MatsubaraDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
Riku HamadaDepartment of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
Shun ShimadaDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
Tomomi YamaguchiDepartment of Medical Genetics, Shinshu University School of Medicine, Matsumoto, Japan.
Keiko WakuiDepartment of Medical Genetics, Shinshu University School of Medicine, Matsumoto, Japan.
Osamu MiyazakiDepartment of Radiology, National Center for Child Health and Development, Tokyo, Japan.
Koji MuroyaDepartment of Endocrinology and Metabolism, Kanagawa Children's Medical Center, Yokohama, Japan.
Kenji KurosawaDivision of Medical Genetics, Kanagawa Children's Medical Center, Yokohama, Japan.ORCID http://orcid.org/0000-0002-6817-7748
Maki FukamiDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.ORCID http://orcid.org/0000-0001-9971-4035
Tsutomu OgataDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.ORCID http://orcid.org/0000-0001-7178-9991
Tomoki KoshoDepartment of Medical Genetics, Shinshu University School of Medicine, Matsumoto, Japan.ORCID http://orcid.org/0000-0002-8344-7507
Masayo KagamiDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan. kagami-ms@ncchd.go.jp.
National Center For Child Health and Development · JPShinshu University · JPKanagawa Children's Medical Center · JPKeio University · JPHamamatsu University School of Medicine · JP

Funding

Japan Agency for Medical Research and Development (AMED) 20ek0109373h0003MEXT | Japan Society for the Promotion of Science (JSPS) 18K06356National Center for Child Health and Development (NCCHD) 2019A-1, 2019B-4
6 · The paper itself

Abstract

Silver-Russell syndrome (SRS) is a congenital disorder characterized by prenatal and postnatal growth failure and craniofacial features. Hypomethylation of the H19/IGF2:IG-differential methylated region (H19LOM) is observed in 50% of SRS patients, and 15% of SRS patients with H19LOM had multilocus imprinting disturbance (MLID). Schimke immuno-osseous dysplasia (SIOD), characterized by spondyloepiphyseal dysplasia and nephropathy, is an autosomal recessive disorder caused by mutations in SMARCAL1 on chromosome 2. We report a patient with typical SRS-related features, spondyloepiphyseal dysplasia, and severe nephropathy. Molecular analyses showed H19LOM, paternal uniparental isodisomy of chromosome 2 (iUPD(2)pat), and a paternally inherited homozygous frameshift variant in SMARCAL1. Genome-wide methylation analysis showed MLID in this patient, although it showed no MLID in another patient with SIOD without SRS phenotype. These results suggest that iUPD(2)pat unmasked the recessive mutation in SMARCAL1 and that the SMARCAL1 gene mutation may have no direct effect on the patient's methylation defects.

Indexed as

ArteriosclerosisChildChild, PreschoolChromosomes, Human, Pair 2DNA HelicasesDNA MethylationFemaleGenome, HumanGenomic ImprintingHumansInfant, NewbornMaleNephrotic SyndromeOsteochondrodysplasiasPhenotypePrimary Immunodeficiency DiseasesDNA HelicasesSMARCAL1 protein, human

Identifiers

PMID34031513
OpenAlexW3163960002

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.